Having trouble accessing articles? Reset your cache.

CVT-301: Phase IIa data

Top-line data from the double-blind, crossover, international Phase IIa CVT-301-002 trial in 24 PD patients experiencing motor fluctuations showed that a single 50 mg dose of

Read the full 262 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE